We are a global leader in biosimilar and generic medicines, committed to playing a leading role in driving access to medicine worldwide. Our portfolio includes approximately 1 000 molecules covering a broad range of therapeutic areas with over 150 different product and technology combinations.
With a global footprint and 9.6 billion USD in 2020 sales, we would be excited to discuss partnerships in the biosimilar, antibiotic, oncology and respiratory area in our key markets US, Europe and selected countries in Asia Pacific, Latin America and Middle East. We are also open to offerings in other therapeutic areas and complex technology areas, like long acting injectables.
Small Molecules
